Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): United Kingdom Clinical Pharmacy Association
|
Asthma (severe, persistent, patients aged 6+, adults) - omalizumab (rev TA133, TA201): United Kingdom Clinical Pharmacy Association
07 March 2013 (87.29 Kb 25 sec) |
This page was last updated: 01 March 2013